title: Human malignant ascites and histamine-induced protein leakage from the normal microcirculation.
abstract: The accumulation of malignant ascites is a significant cause of morbidity and mortality in patients with intraabdominal malignancies. However, the cause of malignant ascites is unknown. In this study, we used the rat cremaster muscle preparation to determine if and how malignant ascites could produce protein leakage from normal blood vessels which would lead to fluid accumulation in the peritoneal cavity. The rat cremaster muscle, with nerves and blood vessels to the animal intact, was prepared for microscopic observations of the microcirculation. Serum albumin was tagged to fluorescein isothiocyanate and injected into the rat. Fluorescent microscopy was used to quantitate leakage of the tagged albumin into the interstitial tissue. Malignant ascites was collected from a patient with metastatic breast cancer. The ascites fluid was placed on the cremaster muscle and it induced protein leakage from the normal blood vessels of this tissue. Protein leakage was partially blocked by diphenhydramine (10(-4) M) and by mast cell depletion with compound 48/80. There was a high level of C3a in the malignant ascites solution but C3a did not increase during the exposure period. These data suggest that activated complement in malignant ascites may release histamine from mast cells to cause protein leakage of the normal vasculature. The movement of protein into the peritoneal cavity would be followed by water, thus increasing the volume of the ascites and exacerbating the clinical condition.
authors.affiliation: Department of Surgery, University of Louisville School of Medicine, Kentucky 40292.
authors.forename: M J
authors.initials: MJ
authors.lastname: White
authors.forename: F N
authors.initials: FN
authors.lastname: Miller
authors.forename: L S
authors.initials: LS
authors.lastname: Heuser
authors.forename: C G
authors.initials: CG
authors.lastname: Pietsch
mesh_terms: D000818:Animals; D001201:Ascites / Q000378:metabolism*; D001920:Bradykinin / Q000494:pharmacology; D001943:Breast Neoplasms / Q000503:physiopathology; D002199:Capillary Permeability / Q000187:drug effects*; D003176:Complement C3 / Q000032:analysis; D015926:Complement C3a; D004155:Diphenhydramine / Q000494:pharmacology; D005260:Female; D006632:Histamine / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000187:drug effects*; D009132:Muscles / Q000098:blood supply; D051381:Rats; D011919:Rats, Inbred Strains; D012709:Serum Albumin / Q000378:metabolism*
chemical_list: D003176:Complement C3; D012709:Serum Albumin; D015926:Complement C3a; D006632:Histamine; D004155:Diphenhydramine; D001920:Bradykinin